Federated Hermes Portfolio holdings
Federated Hermes is an investment manager that runs mutual funds, ETFs and other portfolios across stocks, bonds, alternative and private markets and liquidity management. It began in 1955 as Federated Investors, set up by three high school classmates: John F. Donahue, Thomas J. Donnelly and Richard B. Fisher. In 2018 the firm bought a majority stake in Hermes Fund Managers, which ran Hermes Investment Management, from the BT Pension Scheme. In 2020 Federated Investors renamed itself Federated Hermes. Its clients include corporations, government entities, insurance companies, foundations, endowments, banks and brokerages.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$436M |
| 2 |
Regions Financial
RF
|
+$313M |
| 3 |
Automatic Data Processing
ADP
|
+$289M |
| 4 |
Intuit
INTU
|
+$288M |
| 5 |
Netflix
NFLX
|
+$253M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class A
GOOGL
|
+$390M |
| 2 |
Teradyne
TER
|
+$320M |
| 3 |
Truist Financial
TFC
|
+$313M |
| 4 |
UnitedHealth
UNH
|
+$287M |
| 5 |
Huntington Bancshares
HBAN
|
+$215M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.03% |
| 2 | Healthcare | 13.59% |
| 3 | Industrials | 13.09% |
| 4 | Financials | 10.33% |
| 5 | Consumer Discretionary | 9.82% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1801
iRadimed
IRMD
$981M
| $16.4K | ﹤0.01% |
172
+2
| +1% | +$182 |
2015 Q3
43 quarters
|
|
1802
Asana
ASAN
$2.57B
| $16.3K | ﹤0.01% |
2,325
-610,583
| -100% | -$4.1M |
2025 Q1
5 quarters
|
|
1803
Rigel Pharmaceuticals
RIGL
$958M
| $15.8K | ﹤0.01% |
403
-498
| -55% | -$15.4K |
2025 Q2
4 quarters
|
|
1804
Ericsson
ERIC
$36.2B
| $15.2K | ﹤0.01% |
1,359
| – | – |
2025 Q1
5 quarters
|
|
1805
Perdoceo Education
PRDO
$1.87B
| $15K | ﹤0.01% |
470
+68
| +17% | +$2.33K |
2024 Q3
7 quarters
|
|
1806
8x8 Inc
EGHT
$302M
| $14.8K | ﹤0.01% |
8,631
-501,936
| -98% | -$1.01M |
2022 Q1
17 quarters
|
|
1807
Praxis Precision Medicines
PRAX
$7.98B
| $14.7K | ﹤0.01% |
44
| – | – |
2025 Q4
2 quarters
|
|
1808
Pangaea Logistics
PANL
$521M
| $14.6K | ﹤0.01% |
+2,241
| New | +$17K |
2026 Q2
0 quarters
|
|
1809
Entrada Therapeutics
TRDA
$177M
| $14.5K | ﹤0.01% |
+1,968
| New | +$18.9K |
2026 Q2
0 quarters
|
|
1810
HSBC
HSBC
$292B
| $14.4K | ﹤0.01% |
151
-8
| -5% | -$730 |
2021 Q2
20 quarters
|
|
1811
Nkarta
NKTX
$112M
| $14.3K | ﹤0.01% |
5,048
-937
| -16% | -$2.64K |
2025 Q1
5 quarters
|
|
1812
Inseego
INSG
$80.5M
| $14.2K | ﹤0.01% |
1,371
+907
| +195% | +$12.2K |
2026 Q1
1 quarter
|
|
1813
Abacus Global Management
ABX
$828M
| $14.1K | ﹤0.01% |
+1,321
| New | +$12.1K |
2026 Q2
0 quarters
|
|
1814
News Corp Class B
NWS
$17.1B
| $14.1K | ﹤0.01% |
504
-8
| -2% | -$238 |
2024 Q1
9 quarters
|
|
1815
Acrivon Therapeutics
ACRV
$71.1M
| $14.1K | ﹤0.01% |
7,924
| – | – |
2025 Q2
4 quarters
|
|
1816
Waters Corp
WAT
$45.5B
| $13.9K | ﹤0.01% |
37
+18
| +95% | +$6.14K |
2024 Q2
8 quarters
|
|
1817
Insmed
INSM
$24.7B
| $13.9K | ﹤0.01% |
130
-538,127
| -100% | -$65.2M |
2023 Q3
11 quarters
|
|
1818
WisdomTree Trust WisdomTree US Quality Dividend Growth Fund
DGRW
$17B
| $13.8K | ﹤0.01% |
+144
| New | +$13.6K |
2026 Q2
0 quarters
|
|
1819
Allient
ALNT
$1.46B
| $13.7K | ﹤0.01% |
133
+63
| +90% | +$4.86K |
2026 Q1
1 quarter
|
|
1820
Commercial Vehicle Group
CVGI
$128M
| $13.6K | ﹤0.01% |
2,938
-3,085
| -51% | -$14.5K |
2023 Q4
10 quarters
|
|
1821
Douglas Dynamics
PLOW
$911M
| $13.4K | ﹤0.01% |
248
+74
| +43% | +$3.41K |
2025 Q2
4 quarters
|
|
1822
Q32 Bio
QTTB
$265M
| $13.4K | ﹤0.01% |
1,050
-1,223
| -54% | -$10.2K |
2024 Q3
7 quarters
|
|
1823
KE Holdings
BEKE
$19.4B
| $13.2K | ﹤0.01% |
905
+57
| +7% | +$939 |
2023 Q1
13 quarters
|
|
1824
Hyliion Holdings
HYLN
$580M
| $13K | ﹤0.01% |
2,489
-4,680
| -65% | -$19.5K |
2026 Q1
1 quarter
|
|
1825
Alcon
ALC
$34.5B
| $13K | ﹤0.01% |
193
| – | – |
2019 Q2
28 quarters
|
|
Similar funds
Federated Hermes's Q2 2026 Portfolio in Review
As of Q2 2026, Federated Hermes held 2,221 positions worth $69.6B, up 13% from $61.5B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
Federated Hermes's Q2 2026 filing shows 173 new, 863 increased, 913 reduced and 183 closed positions. Its largest new stake was AngloGold Ashanti: 2,040,755 shares worth $165M. The largest sale was Alphabet (Google) Class A, an estimated $390M.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 22% a quarter earlier, followed by Healthcare and Industrials.
- Federated Hermes's largest Q2 2026 buy was AngloGold Ashanti: 2,040,755 shares worth $165M.
- Federated Hermes added most to Apple in Q2 2026, an estimated $436M increase.
- Federated Hermes's biggest Q2 2026 reduction was Alphabet (Google) Class A, cutting an estimated $390M.
- Federated Hermes fully exited Centessa Pharmaceuticals in Q2 2026, selling an estimated $81.4M.
- Federated Hermes's ten largest holdings make up 16% of its $69.6B portfolio in Q2 2026.
- Federated Hermes opened 173 new positions and closed 183 in Q2 2026.
- Federated Hermes's portfolio value rose 13% quarter-over-quarter to $69.6B.
Based on Federated Hermes's 13F filing for Q2 2026, filed 12 Aug 2026.